$0.45
▲ +$0.04
(+10.02%)
Vol 408K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$8.4M
ROE
-242.2%
Margin
-26209.5%
D/E
0.00
Beta
1.21
52W
$1–$4
Wall Street Consensus
7 analysts · Apr 20262
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 40.0%
Next Report
May 13, 2026
EPS Estimate: $-0.08
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.08 | — | — |
| Dec 2025 | $-0.22 | $-4.84 | $-4.62 |
| Sep 2025 | $-0.39 | $-0.79 | $-0.40 |
| Jun 2025 | $-0.69 | $-0.52 | +$0.17 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Net Income | — | -$3.8M | -$776K | -$30.2M | $8.3M | -$23.0M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | -242.2% | -242.2% | -242.2% | -242.2% | -242.2% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -26209.5% | -26209.5% | -26209.5% | -26209.5% | -26209.5% |
| Gross Margin | — | 36.5% | 36.5% | 36.5% | 36.5% | 36.5% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 3.09 | 0.73 | 3.09 | 3.09 | 3.09 | 3.27 |
Key Ratios
ROA (TTM)
-203.7%
P/S (TTM)
132.56
P/B
1.4
EPS (TTM)
$-5.70
CF/Share
$-0.27
52W High
$3.85
52W Low
$0.54
$0.54
52-Week Range
$3.85
Financial Health
Free Cash Flow
-$4.0M
Cash
$6.8M
As of Dec 31, 2025
How does GTBP compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
GTBP valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
132.6
▲
932%
above
peers
(12.9)
vs Peers
vs Industry
Pricier
P/B ratio
1.4
▼
42%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
GTBP profitability vs Biotechnology peers
ROE
-242.2%
▼
260%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
-26209.5%
▼
9040%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
36.5%
▼
54%
below
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
-203.7%
▼
336%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
GTBP financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
3.3
▼
26%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
1.2
▲
25%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
GTBP fundamentals radar
GTBP
Peer median
Industry
GTBP profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
GTBP vs peers: key metrics
Top Holders
Top 5: 0.73%Citadel Advisors Llc
0.26%
$34K
Scientech Research LLC …
0.17%
$23K
SeaCrest Wealth Management,…
0.16%
$21K
Jane Street Group, LLC
0.08%
$11K
Integrated Wealth Concepts …
0.06%
$8K
As of Dec 31, 2025
Latest News
No related news yet